Form 4 Page 1 of 2
----------------------------
--------------- OMB APPROVAL
FORM 4 ----------------------------
--------------- OMB Number: 3235-0287
----------------------------
Expires: January 31, 2005
----------------------------
Estimated average burden
hours per response... 0.5
----------------------------
[X] Check this box if no longer subject to
Section 16. Form 4 or Form 5
obligations may continue. See
Instruction 1(b).
(Print or Type Responses)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
------------------------------------------------------------------------------------------------------------------------
1. Name and Address of Reporting Person* 2. Issuer Name and Ticker or Trading Symbol
MacMillan, Stephen Pharmacia Corporation PHA
------------------------------------------------------------------------------------------------------------------------
(Last) (First) (Middle) 3. I.R.S. Identification 4. Statement for
Number of Reporting Month/Day/Year
Person, if an entity 04/16/2003
(voluntary)
100 Route 206 North
------------------------------------------------------------------------------------------------------------------------
(Street) 5. If Amendment,
Date of Original
(Month/Day/Year)
Peapack, NJ 07977
------------------------------------------------------------------------------------------------------------------------
(City) (State) (Zip)
---------------------------------------------------------------
6. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
-------- -------
X Officer (give Other (specify
-------- title below) ------- below)
Sector Vice President
---------------------------------------------------------------
7. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
------
Form filed by More than One Reporting Person
------
---------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
--------------------------------------------------------------------------------------------------------------------------
1. Title of Security 2. Transaction Date 2A. Deemed 3. Transaction 4. Securities Acquired (A)
(Instr. 3) (Month/Day/Year) Execution Code or Disposed of (D)
Date, (Instr.8) (Instr. 3, 4 and 5)
if any ---------------------------------------------------------
(Month/ Code V Amount (A) or Price
Day/ (D)
Year)
--------------------------------------------------------------------------------------------------------------------------
Common 04/16/2003 J(1) 46,850 D
--------------------------------------------------------------------------------------------------------------------------
Common 04/16/2003 J(1) 2,538 D
--------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
5. Amount of 6. Ownership 7. Nature of
Securities Form: Direct Indirect
Beneficially (D) or Indirect (I) Beneficial
Owned Following (Instr. 4) Ownership
Reported Transaction(s) (Instr. 4)
(Instr. 3 and 4)
------------------------------------------------------------------------------------
0 D
------------------------------------------------------------------------------------
0 I Savings Plans
------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
------------------------------------------------------------------------------------
Form 4 Page 2 of 2
Table II - Derivative Securities Acquired, Disposed of, or
Beneficially Owned (e.g., puts, calls,
warrants, options, convertible securities)
--------------------------------------------------------------------------------------------------------------------
1. Title of Derivative 2. Conver- 3. Trans- 3A. Deemed Execution 4. Transac- 5. Number of
Security (Instr. 3) sion or action Date, if any tion Code Derivative
Exercise Date (Month/Day/Year) (Instr. 8) Securities
Price of (Month/ Acquired (A)
Derivative Day/ or Disposed of
Security Year) (D) (Instr. 3, 4
and 5)
-----------------------------------
Code V (A) (D)
--------------------------------------------------------------------------------------------------------------------
Option (right to buy) $42.73 04/16/2003 J(1) 100,475
--------------------------------------------------------------------------------------------------------------------
Option (right to buy) $48.88 04/16/2003 J(1) 105,541
--------------------------------------------------------------------------------------------------------------------
Option (right to buy) $46.52 04/16/2003 J(1) 105,541
--------------------------------------------------------------------------------------------------------------------
Option (right to buy) $39.27 04/16/2003 J(1) 182,121
--------------------------------------------------------------------------------------------------------------------
Option (right to buy) $39.27 04/16/2003 J(1) 2,546
--------------------------------------------------------------------------------------------------------------------
Performance Stock Units 1-for-1 04/16/2003 J(1) 21,299
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
--------------------------------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------
6. Date Exercisable 7. Title and Amount of 8. Price of 9. Number of
and Expiration Date Underlying Securities Derivative Derivative
(Month/Day/Year) (Instr. 3 and 4) Security Securities
(Instr. 5) Beneficially
Owned Following
Reported
Transaction(s)
(Instr. 4)
------------------------ ---------------------------
Date Expi- Title Amount or
Exercis- ration Number of
able Date Shares
-------------------------------------------------------------------------------------------
(2) 12/15/2009 Common 100,475 0
-------------------------------------------------------------------------------------------
(2) 05/31/2010 Common 105,541 0
-------------------------------------------------------------------------------------------
(2) 04/02/2011 Common 105,541 0
-------------------------------------------------------------------------------------------
(2) 01/04/2012 Common 182,121 0
-------------------------------------------------------------------------------------------
01/04/2005 01/04/2012 Common 2,546 0
(2)
-------------------------------------------------------------------------------------------
(3) (4) Common 21,299 0
-------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------
-------------------------------------------------------------------------------------------
------------------------------------
10. Ownership 11. Nature
Form of of Indirect
Derivative Beneficial
Securities Ownership
Beneficially (Instr. 4)
Owned at End
of Month
(Instr. 4)
-----------------------------------
D
-----------------------------------
D
-----------------------------------
D
-----------------------------------
D
-----------------------------------
D
-----------------------------------
D
-----------------------------------
-----------------------------------
-----------------------------------
-----------------------------------
-----------------------------------
Explanation of Responses:
(1) Each share of Pharmacia Common Stock (PHA) held by the reporting person was
exchanged for 1.4 shares of Pfizer Common Stock (PFE), pursuant to the
Pfizer/Pharmacia merger agreement adopted by the Pfizer and Pharmacia
shareholders on December 6 & 9, 2002, respectively.
(2) Option is currently exercisable.
(3) At the end of each calendar year 2002, 2003 and 2004, 1/3 of the units will
be eligible for allocation based on Company performance for that year.
(4) Distribution under the plan commences the calendar year following
retirement, termination, death or disability, based on the provisions of
the Savings+Plus deferred compensation plan.
/s/ Don W. Schmitz April 16, 2003
-------------------------------- -----------------
**Signature of Reporting Person Date
Don W. Schmitz, attorney-in-fact
for Stephen MacMillan
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
*If the form is filed by more than one reporting person, see
Instruction 4(b)(v).
**Intentional misstatements or omissions of facts constitute Federal
Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed.
If space is insufficient, see Instruction 6 for procedure.